A Blueprint for Early-Stage Success Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Through a partnership with Velico Inc., a Massachusetts-based medical supply company, South Texas Blood & Tissue will be taking part in a groundbreaking blood preservation technology that could help save even more lives.
Building on its 50-year history of saving and enhancing lives through the healing power of human cells and tissue, BioBridge Global announced today that it is consolidating its end-to-end Cell and Gene Therapy Services portfolio into a new, highly integrated and coordinated operating subsidiary, BBG Advanced Therapies.
BioBridge Global’s R&D Analytical Development team now has a specialized lab to call their own.
As BioBridge Global celebrates its 50th anniversary, the nonprofit and its subsidiaries are evolving to help build the future of healthcare.
BioBridge Global CEO Martin Landon spoke on a panel during the Invest San Antonio 2023-2024 Conference on Thursday, noting the organization’s growing capabilities.
South Texas Blood & Tissue leaders were featured in a webinar on an innovative program to collect whole blood-derived platelets. Audra Taylor (VP, Blood Operations)
BioBridge Global celebrated another major advanced therapies milestone March 1, opening its first stand-alone Cell Therapy Testing Laboratory.